AstraZeneca PLC (OSTO:AZN) is set to release its Q3 2024 earnings on Nov 12, 2024. The consensus estimate for Q3 2024 revenue ...
Check the time stamp on this data. Updated AI-Generated Signals for Astrazeneca Plc (AZN) available here: AZN.
Zacks.com on MSN6d
Are Options Traders Betting on a Big Move in AstraZeneca (AZN) Stock?Investors need to pay close attention to AstraZeneca (AZN) stock based on the movements in the options market lately.
Shore Capital reiterated their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report report ...
The OBR (Office for Budget Responsibility) anticipates economic output in Britain to expand by 1.8% in 2026 and by 1.5% in ...
Fiera Capital Corp trimmed its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.9% during the third quarter, according to the company in its most recent filing with the Securities and ...
Seeking Alpha on MSN5d
AstraZeneca falls as fraud investigation reportedly expands in China (update)An insurance fraud investigation linked to AstraZeneca (AZN) expands in China involving dozens of senior executives. Read ...
AstraZeneca (AZN) stock falls as a Chinese probe into drug importations and data privacy implicates senior and former ...
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on AstraZeneca (AZN – Research Report), with ...
Zacks.com on MSN3d
Astrazeneca (AZN) Surpasses Market Returns: Some Facts Worth KnowingAstrazeneca (AZN) reachead $64.69 at the closing of the latest trading day, reflecting a +1.32% change compared to its last close.
UBS analyst Matthew Weston maintained a Sell rating on AstraZeneca (AZN – Research Report) today and set a price target of £113.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback